A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer
Số trang: 10
Loại file: pdf
Dung lượng: 565.34 KB
Lượt xem: 8
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
We conducted a phase I/Ib, open-label, single-arm trial to assess the safety, tolerability and optimal scheduling regimen of OTSGC-A24 cancer vaccine in patients with advanced gastric cancer.
Nội dung trích xuất từ tài liệu:
A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer
Nội dung trích xuất từ tài liệu:
A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer
Gợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 166 0 0 -
6 trang 165 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 138 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 106 0 0 -
12 trang 86 0 0
-
19 trang 72 0 0
-
17 trang 60 0 0
-
9 trang 35 0 0
-
11 trang 34 0 0
-
12 trang 33 0 0